FR2306706A1 - Agent regulateur intestinal et procede d'obtention - Google Patents

Agent regulateur intestinal et procede d'obtention

Info

Publication number
FR2306706A1
FR2306706A1 FR7610341A FR7610341A FR2306706A1 FR 2306706 A1 FR2306706 A1 FR 2306706A1 FR 7610341 A FR7610341 A FR 7610341A FR 7610341 A FR7610341 A FR 7610341A FR 2306706 A1 FR2306706 A1 FR 2306706A1
Authority
FR
France
Prior art keywords
compsn
regulating agent
procedure
obtaining
intestinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7610341A
Other languages
English (en)
French (fr)
Other versions
FR2306706B1 (enExample
Inventor
Nils Gosta Alvar Nilsson
Mats Oyvind Palsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Draco AB
Original Assignee
Draco AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco AB filed Critical Draco AB
Publication of FR2306706A1 publication Critical patent/FR2306706A1/fr
Application granted granted Critical
Publication of FR2306706B1 publication Critical patent/FR2306706B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR7610341A 1975-04-09 1976-04-08 Agent regulateur intestinal et procede d'obtention Granted FR2306706A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7504053A SE7504053L (sv) 1975-04-09 1975-04-09 Svellmedel

Publications (2)

Publication Number Publication Date
FR2306706A1 true FR2306706A1 (fr) 1976-11-05
FR2306706B1 FR2306706B1 (enExample) 1979-03-16

Family

ID=20324217

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7610341A Granted FR2306706A1 (fr) 1975-04-09 1976-04-08 Agent regulateur intestinal et procede d'obtention

Country Status (12)

Country Link
JP (1) JPS51142546A (enExample)
AU (1) AU1275176A (enExample)
BE (1) BE840555A (enExample)
DE (1) DE2614455A1 (enExample)
DK (1) DK153276A (enExample)
FI (1) FI760960A7 (enExample)
FR (1) FR2306706A1 (enExample)
LU (1) LU74731A1 (enExample)
NL (1) NL7603360A (enExample)
NO (1) NO761087L (enExample)
NZ (1) NZ180551A (enExample)
SE (1) SE7504053L (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3332301A1 (de) * 1983-09-07 1985-03-21 Algina AG, Zug Metallsalze und metallmischsalze von polymeren, anionischen carbonsaeuren und/oder ihren schwefelsaeureestern, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und ihre verwendung
EP0286085A1 (en) * 1987-04-08 1988-10-12 Ferrosan International A/S An antacid composition

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63165325A (ja) * 1986-12-27 1988-07-08 Snow Brand Milk Prod Co Ltd 整腸剤
CN1777434A (zh) * 2003-04-25 2006-05-24 亘起物产有限会社 便秘预防及改善剂

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3332301A1 (de) * 1983-09-07 1985-03-21 Algina AG, Zug Metallsalze und metallmischsalze von polymeren, anionischen carbonsaeuren und/oder ihren schwefelsaeureestern, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und ihre verwendung
EP0286085A1 (en) * 1987-04-08 1988-10-12 Ferrosan International A/S An antacid composition
WO1988007862A1 (en) * 1987-04-08 1988-10-20 Farma Food A/S An antacid composition
US5068109A (en) * 1987-04-08 1991-11-26 Farma Food A/S Antacid composition

Also Published As

Publication number Publication date
NL7603360A (nl) 1976-10-12
NZ180551A (en) 1978-04-28
NO761087L (enExample) 1976-10-12
DK153276A (da) 1976-10-10
FI760960A7 (enExample) 1976-10-10
AU1275176A (en) 1977-10-20
DE2614455A1 (de) 1976-10-28
LU74731A1 (enExample) 1977-02-04
JPS51142546A (en) 1976-12-08
SE7504053L (sv) 1976-10-10
BE840555A (fr) 1976-10-11
FR2306706B1 (enExample) 1979-03-16

Similar Documents

Publication Publication Date Title
FI870356A0 (fi) Foerfarande foer framstaellning av vinylfenolderivat.
GB8817015D0 (en) Method of treatment
Peacher et al. Contact ulcer of the larynx: II. The role of vocal reeducation
Konturek et al. Prevention of ethanol and aspirin-induced gastric mucosal lesions by paracetamol and salicylate in rats: role of endogenous prostaglandins.
Korovitsky The part played by the ducts in the pancreatic secretion
GREENLEE et al. The effect of pancreatic fistula on gastric secretion
FR2417494A1 (fr) Nouvelles compositions analgesiques et antipyretiques contenant un derive de paracetamol
Wright et al. Scleredema adultorum of Buschke with upper esophageal involvement.
FR2352539A1 (fr) Procede et appareil pour la production d'un effet therapeutique dans le corps humain par pression en des endroits determines du corps
FR2346011A1 (fr) Acetanilido-piperazines
Texter Ulcer Pain Mechanisms the Clinical Features of Active Peptic Ulcer Disease and Implications for Therapy
Henderson ACAPNIA AND SHOCK.—III. SHOCK AFTER LAPAROTOMY: ITS PREVENTION, PRODUCTION, AND RELIEF
GR3003872T3 (enExample)
Van Dijk et al. 15-Hydroxy-eicosatetraenoic acid has minor anti-inflammatory properties in colitis
ATE432070T1 (de) Herabgesetzte dosis von tolterodin zur behandlung von harnwegserkrankungen
FR2409759A1 (fr) Nouveau medicament renfermant un mucilage destine a eviter le reflux gastrique et son procede de preparation
DE69428797D1 (de) Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
Fadali et al. Enlarging the Lumen of the Carotid Sinus: An Experimental Treatment of Systemic Arterial Hypertension
RU1805966C (ru) Вещество, обладающее противовоспалительным, биостимулирующим и общеукрепл ющим действием
RU2161477C2 (ru) Способ профилактики рецидива язвенной болезни двенадцатиперстной кишки
Stone Perforation of the Gallbladder Occurring in the Late Stage of Pregnancy
SU1319854A1 (ru) Способ лечени больных первичным гипотиреозом
SU1130345A1 (ru) Способ лечени хронического уретропростатита
RU2004198C1 (ru) Способ лечени долихосигмы и заворота сигмовидной кишки
Kao et al. Respiratory sensitivity to carbon dioxide in cross-circulated dogs

Legal Events

Date Code Title Description
ST Notification of lapse